Cargando…
Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients
BACKGROUND: Cytomegalovirus (CMV) is associated with an increased risk of cardiac allograft vasculopathy (CAV), the major limiting factor for long-term survival after heart transplantation (HTx). The purpose of this study was to evaluate the impact of CMV infection during long-term follow-up after H...
Autores principales: | Johansson, Inger, Andersson, Rune, Friman, Vanda, Selimovic, Nedim, Hanzen, Lars, Nasic, Salmir, Nyström, Ulla, Sigurdardottir, Vilborg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690411/ https://www.ncbi.nlm.nih.gov/pubmed/26703239 http://dx.doi.org/10.1186/s12879-015-1321-1 |
Ejemplares similares
-
Lower incidence of CMV infection and acute rejections with valganciclovir prophylaxis in lung transplant recipients
por: Johansson, Inger, et al.
Publicado: (2013) -
Progression of cardiac allograft vasculopathy assessed by serial three-vessel quantitative coronary angiography
por: Zanchin, Christian, et al.
Publicado: (2018) -
Cardiac allograft vasculopathy in Dutch heart transplant recipients
por: Galli, G., et al.
Publicado: (2016) -
Cardiac Allograft Vasculopathy: A Donor or Recipient Induced Pathology?
por: van den Hoogen, Patricia, et al.
Publicado: (2015) -
The Association Between Cytomegalovirus Infection and Cardiac Allograft Vasculopathy in the Era of Antiviral Valganciclovir Prophylaxis
por: Klimczak-Tomaniak, Dominika, et al.
Publicado: (2019)